Partnervest Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Partnervest Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,154	Closed	-$241K	–	256
2019 Q1	$241K	Sell	2,154 -900	-29%	-$98.7K	0.1%	186
2018 Q4	$294K	Buy	+3,054	New	+$324K	0.14%	140
2015 Q3	–	Sell	-2,403	Closed	-$296K	–	175
2015 Q2	$296K	Hold	2,403	–	–	0.15%	132
2015 Q1	$275K	Buy	2,403 +39	+2%	+$4.3K	0.14%	121
2014 Q4	$239K	Sell	2,364 -210	-8%	-$20.4K	0.12%	127
2014 Q3	$235K	Hold	2,574	–	–	0.12%	131
2014 Q2	$221K	Buy	2,574 +2,364	+1,126%	+$186K	0.1%	142
2014 Q1	$17K	Hold	210	–	–	0.01%	541
2013 Q4	$16K	Hold	210	–	–	0.01%	525
2013 Q3	$15K	Hold	210	–	–	0.01%	542
2013 Q2	$12K	Buy	+210	New	+$12.1K	0.01%	558

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Partnervest Advisory Services's IBB Position: Q2 2019 in Review

Partnervest Advisory Services sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 2,154 shares — an estimated $241K sold.

Partnervest Advisory Services first reported a position in IBB in Q2 2013 and held it in 11 quarters. The position peaked at $296K in Q2 2015. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Partnervest Advisory Services reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Partnervest Advisory Services sold 2,154 iShares Biotechnology ETF shares in Q2 2019, an estimated $241K.
Partnervest Advisory Services first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 11 quarters.
Partnervest Advisory Services's iShares Biotechnology ETF position peaked at $296K in Q2 2015.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Partnervest Advisory Services's 13F filing for Q2 2019, filed 7 Aug 2019.